Antifungal activity of selected medicinal plants extract against human pathogenic fungus candida albicans

Author(s):  
ARUN KUMAR ◽  
VIJAI MALIK ◽  
SHRUTI SAINI
2020 ◽  
Vol 150 ◽  
pp. 02003 ◽  
Author(s):  
Azeddin El Barnossi ◽  
Fatimazahrae Moussaid ◽  
Abdelilah Iraqi Housseini

Candida albicans an opportunistic pathogenic fungus causes many infections in humans. Whereas Aspergillus niger is a fungus that can produce ochratoxins, a group of extremely dangerous secondary metabolites that are classified as potentially carcinogenic to humans and also causing deterioration in grapes, strawberries, etc. The purpose of the current study is to isolate, purify, identify and characterize new microorganisms associated with solid green household waste for the control of C. albicans and A. niger. The antifungal activity of bacterial isolates was carried out in vitro by the agar plug diffusion method, the disk and well diffusion method. The isolate that showed promising activity has been identified by those macroscopic, microscopic and biochemical characteristics. The results obtained in the course of this study showed the isolation of an isolate named Gn-A11-18, which was shown to have significant inhibitory activity with a 42.66% inhibition percentage against A. niger and a 44.66 mm inhibition diameter against C. albicans compared to the controls. The identification of Gn-A11-18 isolate has shown that this isolate belongs to the genus Bacillus with a similarity to Bacillus subtilis and Bacillus tequilensis. In the light of the results of this study, we can suggest that the bioactive compound of Bacillus sp. Gn-A11-18 could become a biological alternate that could have an important role to fight against C. albicans and A. niger.


2009 ◽  
Vol 9 (2) ◽  
pp. 278-287 ◽  
Author(s):  
Duncan Wilson ◽  
Bernhard Hube

ABSTRACT Common iatrogenic procedures can result in translocation of the human pathogenic fungus Candida albicans from mucosal surfaces to the bloodstream. Subsequent disseminated candidiasis and infection of deep-seated organs may occur if the fungus is not eliminated by blood cells. In these cases, fungal cells adhere to the endothelial cells of blood vessels, penetrate through endothelial layers, and invade deeper tissue. In this scenario, endothelial adhesion events must occur during circulation under conditions of physiological blood pressure. To investigate the fungal and host factors which contribute to this essential step of disseminated candidiasis, we have developed an in vitro circulatory C. albicans-endothelium interaction model. We demonstrate that both C. albicans yeast and hyphae can adhere under flow at a pressure similar to capillary blood pressure. Serum factors significantly enhanced the adhesion potential of viable but not killed C. albicans cells to endothelial cells. During circulation, C. albicans cells produced hyphae and the adhesion potential first increased, then decreased with time. We provide evidence that a specific temporal event in the yeast-to-hyphal transition, regulated by the G1 cyclin Hgc1, is critical for C. albicans-endothelium adhesion during circulation.


2002 ◽  
Vol 368 (1) ◽  
pp. 23-27 ◽  
Author(s):  
Douglas R. HOUSTON ◽  
Ian EGGLESTON ◽  
Bj⊘rnar SYNSTAD ◽  
Vincent G.H. EIJSINK ◽  
Daan M.F. van AALTEN

Family 18 chitinases are attractive targets for the development of new inhibitors with chemotherapeutic potential against fungi, insects and protozoan/nematodal parasites. Although several inhibitors have been identified, these are based on complex chemistry, which hampers iterative structure-based optimization. Here we report the details of chitinase inhibition by the natural product peptide CI-4 [cyclo-(l-Arg-d-Pro)], which possesses activity against the human pathogenic fungus Candida albicans, and describe a 1.7Å (0.17nm) crystal structure of CI-4 in complex with the enzyme. The structure reveals that the cyclic dipeptide inhibits chitinases by structurally mimicking a reaction intermediate, and could, on the basis of its accessible chemistry, be a candidate for further optimization.


2019 ◽  
Vol 10 (4) ◽  
pp. 3121-3126
Author(s):  
Sunayana Manipal ◽  
Lubna Fathima ◽  
Sajid T Hussain ◽  
Venkat R

The aim of the study was to test the anti-bacterial, and anti-fungal activity of four medical plants extract the A.arabica, T.chebula, A.indica, and V.vinifera against the streptococcus mutants and Candida albicans organisms. The extracts obtained from the medicinal plant of A.arabica, T.chebula, A.indica, and V.vinifera was procured and powdered. The minimum inhibitory concentration of the obtained extracts was determined by using the tube dilution method, and the bacterial strains of Streptococcus mutants and Candida albicans were cultured into the extract obtained at a concentration of 1mg/ml, 500µg/ml, 250µg/ml, and 100µg/ml respectively. The extracts obtained from A.arabica and T.chebula had a better anti-bacterial property when compared to the other two medicinal plants and the extracts obtained from A.indica and V.vinifera had a better anti-fungal property when compared to the other two medicinal plants. These plants extracts showed the anti-bacterial property in previous studies to add on to the review of literature in our study it proved that A.indica and V.vinifera had a better anti-fungal activity when compared to another two medicinal plant extract. The clinical significance of the medicinal plant extract can be effectively used as an anti-bacterial and anti-fungal agent as it was compared with the gold standard values of Streptomycin and Amphotericin B.


Microbiology ◽  
2005 ◽  
Vol 151 (10) ◽  
pp. 3381-3394 ◽  
Author(s):  
Donika Kunze ◽  
Inga Melzer ◽  
Désirée Bennett ◽  
Dominique Sanglard ◽  
Donna MacCallum ◽  
...  

Phospholipases C are known to be important regulators of cellular processes but may also act as virulence factors of pathogenic microbes. At least three genes in the genome of the human-pathogenic fungus Candida albicans encode phospholipases with conserved phospholipase C (Plc) motifs. None of the deduced protein sequences contain N-terminal signal peptides, suggesting that these phospholipases are not secreted. In contrast to its orthologue in Sacharomyces cerevisiae, CaPLC1 seems to be an essential gene. However, a conditional mutant with reduced transcript levels of CaPLC1 had phenotypes similar to Plc1p-deficient mutants in S. cerevisiae, including reduced growth on media causing increased osmotic stress, on media with a non-glucose carbon source, or at elevated or lower temperatures, suggesting that CaPlc1p, like the Plc1p counterpart in S. cerevisiae, may be involved in multiple cellular processes. Furthermore, phenotypic screening of the heterozygous ΔCaplc1/CaPLC1 mutant showed additional defects in hyphal formation. The loss of CaPLC1 cannot be compensated by two additional PLC genes of C. albicans (CaPLC2 and CaPLC3) encoding two almost identical phospholipases C with no counterpart in S. cerevisiae but containing structural elements found in bacterial phospholipases C. Although the promoter sequences of CaPLC2 and CaPLC3 differed dramatically, the transcriptional pattern of both genes was similar. In contrast to CaPLC1, CaPLC2 and CaPLC3 are not essential. Although Caplc2/3 mutants had reduced abilities to produce hyphae on solid media, these mutants were as virulent as the wild-type in a model of systemic infection. These data suggest that C. albicans contains two different classes of phospholipases C which are involved in cellular processes but which have no specific functions in pathogenicity.


2014 ◽  
Vol 2014 ◽  
pp. 1-27 ◽  
Author(s):  
Julian R. Naglik

The human pathogenic fungus Candida albicans is the predominant cause of both superficial and invasive forms of candidiasis. C. albicans primarily infects immunocompromised individuals as a result of either immunodeficiency or intervention therapy, which highlights the importance of host immune defences in preventing fungal infections. The host defence system utilises a vast communication network of cells, proteins, and chemical signals distributed in blood and tissues, which constitute innate and adaptive immunity. Over the last decade the identity of many key molecules mediating host defence against C. albicans has been identified. This review will discuss how the host recognises this fungus, the events induced by fungal cells, and the host innate and adaptive immune defences that ultimately resolve C. albicans infections during health.


2007 ◽  
Vol 73 (2) ◽  
pp. 256-258 ◽  
Author(s):  
V. Steenkamp ◽  
A.C. Fernandes ◽  
C.E.J. Van Rensburg

2009 ◽  
Vol 20 (14) ◽  
pp. 3363-3373 ◽  
Author(s):  
Pierre Côte ◽  
Hervé Hogues ◽  
Malcolm Whiteway

We have examined the periodic expression of genes through the cell cycle in cultures of the human pathogenic fungus Candida albicans synchronized by mating pheromone treatment. Close to 500 genes show increased expression during the G1, S, G2, or M transitions of the C. albicans cell cycle. Comparisons of these C. albicans periodic genes with those already found in the budding and fission yeasts and in human cells reveal that of 2200 groups of homologous genes, close to 600 show periodicity in at least one organism, but only 11 are periodic in all four species. Overall, the C. albicans regulatory circuit most closely resembles that of Saccharomyces cerevisiae but contains a simplified structure. Although the majority of the C. albicans periodically regulated genes have homologues in the budding yeast, 20% (100 genes), most of which peak during the G1/S or M/G1 transitions, are unique to the pathogenic yeast.


Sign in / Sign up

Export Citation Format

Share Document